Summary
To examine the clinical efficacy and the mechanism of action of polysaccharide K (PSK), a proteinbound polysaccharide extracted from a Basidiomycetes fungus, a randomized double-blind trial was performed by administering PSK to 56 patients and a placebo to another group of 55 patients after surgical operations on their colorectal cancers. The rate of patients in remission (or disease-free) was significantly higher in the PSK group than in the placebo group; the difference between both groups was statistically significant atP <0.05 by the logrank test. The survival rate of patients was also significantly (P <0.05) higher in the PSK group than in the control group. The most significant laboratory finding was that polymorphonuclear leukocytes from PSK-treated patients showed remarkable enhancement in their activities, such as random and/or chemotactic locomotion, and phagocytic activity, when compared with those in the control group. In conclusion, PSK was useful as a maintenance therapy for patients after their curative surgical operations for colorectal cancer. The beneficial effects were probably due to the activation of leukocyte functions as one of the many biological-response-modifying (activities induced by PSK).
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Akiyama J, Kawamura T, Gotohda E, Yamada Y, Hosokawa M, Kodama T, Kobayashi H (1977) Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Cancer Res 37: 3042
Easmon CSF, Cole PJ, Williams AJ, Hastings M (1980) The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence. Immunology 41: 67
Hayashi Y, Torisu M (1990) New approach to management of malignant ascites with a streptococcal preparation OK-432 III. OK-432 attracts NK cells through a chemotactic factor released from activated neutrophils. Surgery 107: 74
Ikeda T, Sakai T, Saito T, Kosaki G (1986) Evaluation of Postoperative immunochemotherapy for lung cancer patients. Jpn J Cancer Chemother 13: 1044
Itoh I, Sakai T, Mori T (1979) Aspects of immunological antitumor agent and its clinical use PSK. Jpn J Cancer Chemother 6: 681
Iwasaki K, Torisu M, Fujimura T (1986) Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer 58: 1321
Japanese Research Society for Cancer of Colon and Rectum (1977) General rules for clinical and pathological studied on cancer of colon, rectum and anus.
Katano M, Torisu M (1983) New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Surgery 93: 365
Katano M, Tanaka M, Okano H, Torisu M (1980) Ambidextrous effect of PSK on motilities of both macrophages and tumor cells. Proc Am Soc Exp Biol 39: 476
Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y (1977) Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared fromCoriolus versicolor. Cancer Res 37: 4416
Kondo M, Torisu M (1985) Evaluation of an anticancer activity of a protein-bound polysaccharide PS-K (Krestin). In: Torisu M, Yoshida T (eds) Basic mechanisms and clinical treatment of tumor metastasis. Academic Press, New York, P 623
Kondo M, Kato H, Yokoe N, Natsumura N, Hotta T, Masuda M (1978) Activation of the complement by immunostimulants, BCG, OK-432 (Picibanil), and PS-K (Krestin) in vivo. Gann 69: 669
Koshimura S, Shimizu R, Fujimura A, Okamoto H (1964) Experimental anticancer studies. XXI. Effect of penicillin treatment of hemolyticStreptococcus on its anticancer activity. Gann 55: 233
Kumashiro R, Hiramoto Y, Okamura T, Kano T, Sano CC, Inokuchi K (1985) Postoperative long-term immunostimulatory protein-bound polysaccharide Kureha (PSK) therapy for advanced gastric cancer. In: Torisu M, Yoshida T (eds) Basic mechanisms and clinical treatment of tumor metastasis. Academic Press, New York, p 523
Linell F, Mansson B (1954) The prognostic value of eosinophilic leukocytes in the stroma of carcinoma of the cervix uteri. Acta Rasdiol 41: 453
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 2: 235
Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger LR, Mayat M, de Vassal F (1969) Active immunotherapy for acute lymphoblastic leukemia. Lancet 1: 697
Mathé G, Schwarzenberg L, de Vassal F, Delgado M (1976) Immunotherapy for acute lymphoid leukemia. Lancet 1: 143
Mayer MM (1961) Experimental immunochemistry, 2nd edn. Thomas, Springfield Ill, p 135
Mitomi T, Ogoshi K (1986) Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer. Jpn J Cancer Chemother 13: 2532
Morton DL, Eilber FR, Malmgren RA, Wood WC (1970) Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68: 158
Morton DL, Eilber FR, Holmes EC, Sparkes FC, Ramming KP (1976) Present status of BCG immunotherapy of malignant melanoma. Cancer Immunol Immunother 1: 93
Nagell JR, Donaldson ES, Wood EG, Parker JC (1978) The significance of vascular invasion and lymphocytic infiltration in invasive cervical carcinoma. Cancer 41: 228
Nakazato H, Ichihashi H, Kondo T (1986) Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin for patients with curatively resected gastric cancer. Jpn J Cancer Chemother 13: 308
Niimoto M, Toge T, Nakano A, Yanagawa E, Oride M, Hirano M, Nakanishi K, Nosou Y, Yamada Y, Hattori T (1981) Adjuvant immunochemotherapy in patients with gastric cancer. Jpn J Gastroenterol Surg 14: 704
Nishioka K, Linscott WD (1963) Components of guinea pig complement I. Separation of a serum fraction essential for immune hemolysis and immune adherence. J Exp Med 118: 767
Nomoto K, Yoshikumi C, Matsunaga K, Fujii T, Takeya K (1975) Restoration of antibody-forming capacities by PS-K in tumor-bearing mice. Gann 66: 365
Okamoto H, Shoin S, Koshimura S, Shimizu R (1973) Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11: 323
Pretlow TP, Keith EF, Cryar AK (1983) Eosinophil infiltration of human colonic carcinomas as a prognostic indication. Cancer Res 43: 2997
Shiraki S, Mori H, Ito A, Kadomoto N, Yamagiwa S, Yamada Y, Noda K (1982) Adjuvant immunotherapy for carcinoma of uterine cervix with PSK. Jpn J Cancer Chemother 9: 1031
Tachibana T, Ishikawa M (1973) Quantitation of T and B lymphocyte. Jpn J Exp Med 43: 227
Taguchi T (1979) Clinical studies on PSK: combination therapy of PSK with surgery and chemotherapy. Recent Results Cancer Res 68: 236
Torisu M, Fukawa M, Nishimura M, Harasaki H, Kai S, Tanaka J (1976) Immunotherapy of cancer patients with bacillus Calmette-Guérin: summary of four years of experience in Japan. Ann NY Acad Sci 277: 160
Torisu M, Katano M, Kimura Y, Itoh H, Takesue M (1983) New approach to management of malignant ascites with a streptococcal preparation of survival. Surgery 93: 357
Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K (1984) Krestin (PSK). Cancer Treat Rev 11: 131
Uchida A, Hoshino T (1980) Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Cancer 45: 476
Ward PA, Cochrane CG, Müller-Eberhard HJ (1965) The role of serum complement in chemotaxis of leukocytes in vitro. J Exp Med 122: 327
Ward PA, Lepow IH, Newman LJ (1968) Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol 52: 725
Watanabe Y, Iwa T (1984) Clinical value of immunotherapy by streptococcal preparation, OK-432, for lung cancer: a randomized study: In: Hoshino T, Uschida A (eds) Clinical and Experimental Studies in Immunotherapy Excerpta Medica, Amsterdam, p 120
Watanabe H, Enjohji M, Imai T (1976) Gastric carcinoma with lymphoid stroma: Its morphologic characteristics and prognostic correlations. Cancer 38: 232
Yoshikuni C. Nomoto K, Matsunaga K, Fujii T, Takeya K (1975) Mouse strain difference in expression of antitumor activity of PS-K. Gann 66: 649
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Torisu, M., Hayashi, Y., Ishimitsu, T. et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 31, 261–268 (1990). https://doi.org/10.1007/BF01740932
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01740932